COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: They receive both usual treatments (Fifth Edition of the Novel Corona Virus Guidelines: hydroxychloroquine/chloroquine phosphate with or without lopinavir/ritonavir
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Suffering from COVID-19 based on Positive nasopharyngeal RT-PCR test or CT of the chest 18 years old or more Informed consent
Exclusion criteria
Exclusion criteria: Intubated patient or hospitalized in the ICU Pregnant and lactating women Diabetes Patients treated with corticosteroids or immunosuppressive drugs Use of herbal medicines or other traditional and complementary medicine methods Dialysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tempreture. Timepoint: Daily. Method of measurement: Thermometer.;Cough. Timepoint: Daily. Method of measurement: Fisman scale.;Respiratory rate. Timepoint: Daily. Method of measurement: Counting the number of breaths per minute.;Weakness. Timepoint: Daily. Method of measurement: Visual analog scale.;Muscular pain. Timepoint: Daily. Method of measurement: Visual analog scale.;C Reactive Protein (CRP). Timepoint: Daily. Method of measurement: Blood test.;Lymphocyte count. Timepoint: Daily. Method of measurement: Blood test.;O2 Saturation percentage (SpO2). Timepoint: Daily. Method of measurement: Pulse oximetery.;Chest X ray. Timepoint: Daily. Method of measurement: Analysis of radiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of admission days. Timepoint: Daily. Method of measurement: Counting admission days.;Mortality. Timepoint: Daily. Method of measurement: The ratio of death to total patients in each group.;Adverse effect. Timepoint: Daily. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoshanak Mokaberinejad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed